Health Affairs November 17, 2025
Editor’s Note
This article is the latest in the Health Affairs Forefront featured topic, “Health Policy At A Crossroads,” produced with the support of the Commonwealth Fund and the Robert Wood Johnson Foundation. Articles in this topic offer timely analyses of regulatory, legislative, and judicial developments in health policy under the Trump-Vance administration and the 119th Congress. Health Affairs Forefront alone reviews all submissions then selects, edits, and publishes them only if they meet Forefront’s editorial standards.
This fall, as millions of Americans seek protection from respiratory viruses, the federal agencies entrusted with safeguarding their health have instead not only sown uncertainty but deepened it. In June, the Food and Drug Administration narrowed the approved, on-label use of updated COVID-19...
Today's Sponsors
Today's Sponsor